Novavax reports positive preclinical results on its novel vaccine for pandemic influenza [Primary member]
submitted by kickingbird at Aug, 26, 2005 from PRNewswire
Novavax, Inc.(Nasdaq: NVAX), a specialty biopharmaceutical company, today reportedpreclinical results on the Company´s novel Virus-Like Particle (VLP) influenzavaccine. Novavax´s biological group ...
Biodem Receives $US1 Million From Akzo Nobel for Flu Vaccine [Primary member]
submitted by kickingbird at Aug, 2, 2005 from Australian Associated Press
Dutch pharmaceutical company Nobilon has paid Melbourne-based drug developer Biodem $1 million now that the company´s intranasal flu vaccine has met the requirements needed to be produced in chicken ...
Sinovac Biotech Ltd. Receives Flu Vaccine Production License from Chinese FDA [Primary member]
submitted by kickingbird at Jul, 28, 2005 from businesswire
BEIJING--(BUSINESS WIRE)--July 27, 2005--Sinovac Biotech Ltd. ("Sinovac") ("the Company") (AMEX:SVA) announced today that the State Food and Drug Administration (SFDA) issued a production license for Sinovac´s ...
Biota announced Date Change For Damages Filing In GSK Law Suit [Primary member]
submitted by kickingbird at Jul, 21, 2005 from PRNewswire
Biota announced today that it would be filing its Particulars of Loss and Damage in the suit against GlaxoSmithKline (GSK) during the week beginning July 25, rather than on July 22 as previously advised. ...
Sanofi pasteur to Increase U.S. Influenza Vaccine Capacity With Construction of New Plant [Primary member]
submitted by kickingbird at Jul, 21, 2005 from PRNewswire (via http://biz.yahoo.com/prnews/050720/nyw048.html?.v=16)
Work officially began today on the construction of a new sanofi pasteur manufacturing facility that will expand the ability of the United States to produce influenza vaccine for both routine influenza ...
Roche Posts Very Strong Interim Results [Primary member]
submitted by kickingbird at Jul, 20, 2005 from PRNewswire (via http://www.medadnews.com/News/index.cfm?articleid=257612&quo)
Roche Group - Group sales up 17%. Pharmaceutical sales grow three times faster than the global market - Operating profit rises 30%, outpacing sales growth - Positive net financial income - Net income reaches ...
Chiron: Will Not Supply BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets for the 2005-2006 Influenza Season [Primary member]
submitted by kickingbird at Jul, 20, 2005 from PRNewswire
Chiron Will Not Supply BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets for the 2005-2006 Influenza Season; Company is Working to Cover BEGRIVAC Vaccine Shortfall with Other Non-U.S. Influenza ...
Canada:Flu vaccine shortage predicted [Primary member]
submitted by kickingbird at Jul, 9, 2005 from National Post (via http://www.canada.com/search/story.html?id=b140906d-df5a-4f3)
Hundreds of thousands of healthy Canadian adults may have to forego a flu shot this year after a key manufacturer cut short its production run to prepare for expansion into foreign markets.
ID Biomedical ...
FluMist Flier Is Misleading, FDA Says [Primary member]
submitted by kickingbird at Jun, 29, 2005 from washington post (via http://www.washingtonpost.com/wp-dyn/content/article/2005/06)
The Food and Drug Administration has ordered MedImmune Inc. to stop distributing a promotional flier for its nasal flu vaccine FluMist because, the agency said, it misled consumers by not disclosing the ...
Chiron: shrinks estimate of flu vaccine production
submitted by kickingbird at Jun, 17, 2005 from Chiron PRNews
Chiron Revises Production Range for FLUVIRIN Vaccine and Updates Financial Guidance; Delays in Reaching Full-Scale Production Expected to Reduce Doses and EPS; Full FDA cGMP Inspection of Liverpool ...
Protein Sciences Announces Excellent Efficacy Results for FluBlOk(TM), its Recombinant Influenza Vaccine [Primary member]
submitted by kickingbird at Jun, 15, 2005 from Protein Sciences Corporation (via http://biz.yahoo.com/prnews/050614/nytu152.html?.v=11)
MERIDEN, Conn., June 14 /PRNewswire/ -- Protein Sciences Corporation announced today preliminary results from its first field efficacy study of FluBlOk(TM), a patented influenza vaccine that is produced ...
Solvay Pharmaceuticals, Inc. Submits Drug Master File for Cell-Derived Influenza Vaccine to U.S. Food and Drug Administration; Cell Culture Production Facility Construction Completed in The Netherland [Primary member]
submitted by kickingbird at Jun, 8, 2005 from bussinesswire
MARIETTA, Ga.--(BUSINESS WIRE)--June 7, 2005--Solvay Pharmaceuticals, Inc. announced today that it has submitted a drug master file (DMF) to the U.S. Food and Drug Administration (FDA) for its cell-derived ...
Supply, demand concerns dominate flu vaccine meeting [Primary member]
submitted by kickingbird at May, 13, 2005 from ASSOCIATED PRESS (via http://www.suntimes.com/output/news/flu11.html)
Uncertainties over vaccine supply and demand dominated a two-day brainstorming session for the upcoming flu season, where public health officials and manufacturers discussed ways to avoid a crisis like ...
Vietnam to test bird flu vaccine on 600,000 chickens in Ho Chi Minh City [Primary member]
submitted by kickingbird at May, 4, 2005 from AP (via http://asia.news.yahoo.com/050504/ap/d89s4bm81.html)
Some 600,000 chickens in Vietnam´s southern commercial hub will be vaccinated against bird flu in an attempt to control the deadly virus, an official said Wednesday.
The vaccine produced by French ...
MedAmerica, Inc. Offers Comprehensive Influenza Data for Health Care Planning [Primary member]
submitted by kickingbird at Apr, 23, 2005 from PRNewswire
Valuable information regarding influenza and flu-like illnesses based on statewide clinical experience is now available to medical professionals. Gathered from 800 California physicians and 300 physician ...
MedImmune Reports Financial Results for First Quarter 2005 [Primary member]
submitted by kickingbird at Apr, 22, 2005 from PRNewswire
Recent Highlights * Sales of Synagis(R) increased 12 percent to $472 million * FluMist supplements approved by FDA to reduce normal allantoic fluid ...
Denka Seiken to Market Influenza Vaccine Through Takeda Pharmaceutical [Primary member]
submitted by kickingbird at Apr, 20, 2005 from The Japan Corporate News Network (via http://www.japancorp.net/Article.Asp?Art_ID=9891)
Tokyo (JCNN) - Denka Seiken (TSE: 4561) announced on April 18 that it has agreed with Takeda Pharmaceutical (TSE: 4502) to collaborate in the sale of its influenza vaccine. Specifically, Denka Seiken will ...
Sinovac Biotech Ltd. Issues Corporate Update [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire
BEIJING--(BUSINESS WIRE)--April 18, 2005--Sinovac Biotech Ltd. ("Sinovac") ("the Company") (AMEX:SVA) today updates on the status of the vaccines comprising its product portfolio.
Hepatitis A - Healive(TM) ...
Amarillo Biosciences, Inc. Announces Progress Report to Shareholders and Annual Meeting Agenda [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire (via http://www.marketwire.com/mw/release_html_b1?release_id=8483)
AMARILLO, TX -- (MARKET WIRE) -- 04/18/2005 -- Amarillo Biosciences, Inc. (ABI) (OTC BB: AMAR) announces that proxy material is being mailed to its approximately 1,400 shareholders of record as of April ...
Roche Files Supplemental New Drug Application to Extend Prophylaxis Indication for Tamiflu(R) to Patients Between One to 12 Years of Age [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire (via http://biz.yahoo.com/prnews/050418/nym048.html?.v=7)
NUTLEY, N.J., April 18 /PRNewswire/ -- Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA), requesting an extension of the prophylaxis indication ...
144 items, 20/Page, Page[3/8][|<<] [|<]         [>|] [>>|]
Northen China: Beijing - Gansu -
Inner mongolia -
Southen China: Anhui -